Q2 2024

Filed Aug 13, 2024 · 10-Q · 44 days after period end · 0000950170-24-096189

Q2 2024 · 10-Q

Revenue

$0.00

no prior Q2 2023 on file

Net Income

-$21.83M

N/M vs Q2 2023

EPS Diluted

-$2.43

N/M vs Q2 2023

Operating Income-$24,125,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2022	Q2 2021
Revenue	$0.00	—	$0.00	$9.42M
Net Income	-$21.83M	-$17.65M	-$21.29M	-$17.66M
EPS Diluted	-$2.43	-$63.83	-$0.61	-$0.52

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Korro Bio, Inc. · CIK 1703647 · Engraved from SEC EDGAR